HOME >> MEDICINE >> NEWS
Controversies regarding ovarian cancer treatments addressed

Trials have raised questions on the current management and standard of care for advanced ovarian cancer (AOC). These controversies highlight implications for future clinical research and policy-making, as reviewed in an article published in the International Journal of Gynecological Cancer.

According to the paper, ovarian cancer is one of the leading causes of cancer-related death in women though unfortunately, the disease is only diagnosed at advanced stages. This study, led by Max S. Mano, Consultant Medical Oncologist, critically analyzes and highlights potential caveats in the controversial issues involved in AOC management.

Surgery, chemotherapy, dosage and duration are among the topics reviewed to "reconstruct the development of the current standard first-line therapy for AOC" due to the crucial questions remaining regarding optimal management even after research has moved forward. Such questions include whether the doublet platinum-cyclophosphamide, used in chemotherapy, was actually the best comparator for now standard platinum-paclitaxel; also questioned was the potential of higher doses.

"Unfortunately, these questions are unlikely to be definitively answered as the interest is now moving towards other more relevant issues, such as the incorporation of biological therapies and new agents into clinical practice," states Mano. "It is however important that oncologists who will be facing patients with their particularities and a wide range of clinical situations, be aware of such controversies as this may occasionally influence their decisions in daily practice."

Mano stresses the importance of avoiding similar mistakes in developing future clinical trials and suggests that this review could be an additional source of reference for policy-makers.


'"/>

Contact: Sharon Agsalda
medicalnews@bos.blackwellpublishing.com
781-388-8507
Blackwell Publishing Ltd.
10-Nov-2004


Page: 1

Related medicine news :

1. Yale authors raise concerns regarding regionalized heart attack care
2. Drug that hinders blood vessel growth under study in ovarian cancer
3. USC researchers find evidence that progesterone signaling influences ovarian cancer risk
4. New protein associated with aggressiveness in breast and ovarian cancer
5. Fox Chase Cancer Center researchers identify novel target for detecting ovarian cancer in blood
6. Coronal reformatting of axial images from 16-MDCT helps stage ovarian cancer
7. Changes in ovaries could indicate higher risk of ovarian cancer
8. Experimental drug used to treat recurrent ovarian cancer shows promising results
9. First peer-support helpline for people concerned about hereditary breast and ovarian cancer
10. Detection of glycoprotein could indentify ovarian and uterine cancers with poor prognosis
11. Removal of ovaries for young women with breast cancer and family history of ovarian cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/14/2019)... ... 14, 2019 , ... KICVentures , an investment holding company in healthcare, ... its two disruptive spine portfolio companies, AxioMed LLC and NanoFUSE Biologics ... The spine industry is consolidating evidenced by multiple acquisitions , creating a favorable ...
(Date:2/13/2019)... ... February 13, 2019 , ... Following the longest federal ... the American Academy of Sleep Medicine (AASM) is warning that such shutdowns exacerbate ... and Transportation Security Administration (TSA) officers. , “Even in typical circumstances, safety may ...
(Date:2/13/2019)... NEW YORK & GREENWICH, Conn. (PRWEB) , ... February 13, 2019 ... ... peaceful – unless you must clear the white stuff from walkways and driveways. Then, ... ankle -- just about any joint or muscle you use to remove it,” says ...
(Date:2/13/2019)... ... February 13, 2019 , ... A Place at Home ... Home Care Pulse. The Employer of Choice Award is granted only to the top-ranking ... independent satisfaction research firm for home care. A Place at Home is ranked among ...
(Date:2/13/2019)... , ... February 13, 2019 , ... ... lifestyle publication is privileged to present Dr. David A. Lickstein as a leading ... Beauty offers a prominent collective of leading doctors. The invitation-only exclusive publication maintains ...
Breaking Medicine News(10 mins):
(Date:2/13/2019)... PARK, Texas (PRWEB) , ... February 13, 2019 ... ... new CD8801 and CD8826 Thin Clients at HIMSS 2019 US in Orlando, Florida. ... manufacturing industries at low prices of $199 and $520 and above respectively. ...
(Date:2/13/2019)... ... February 13, 2019 , ... Gastro Health, LLC (“Gastro ... Gastroenterology Center, P.A. DBA Gastroenterology Specialists (“Gastroenterology Specialists”), a leading physician group with ... acquisition in the Central Florida market, after it acquired Central Florida Gastroenterology in ...
(Date:2/13/2019)... Utah (PRWEB) , ... February 13, 2019 , ... Published ... Music to Reduce Auditory Hypersensitivity in Children appears in Vol 11, No 1 ... and Alex Doman founder of Advanced Brain Technologies .     , ...
Breaking Medicine Technology:
Cached News: